Arvinas, Inc. (ARVN)
NASDAQ: ARVN · Real-Time Price · USD
25.32
-0.40 (-1.56%)
Dec 3, 2024, 12:29 PM EST - Market open
Arvinas Revenue
Arvinas had revenue of $102.40M in the quarter ending September 30, 2024, with 195.95% growth. This brings the company's revenue in the last twelve months to $161.10M, up 1.07% year-over-year. In the year 2023, Arvinas had annual revenue of $78.50M, down -40.26%.
Revenue (ttm)
$161.10M
Revenue Growth
+1.07%
P/S Ratio
11.05
Revenue / Employee
$362,022
Employees
445
Market Cap
1.74B
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Fortrea Holdings | 2.98B |
GoodRx Holdings | 790.39M |
Certara | 372.80M |
Galapagos NV | 290.09M |
MannKind | 267.20M |
RxSight | 128.29M |
Xencor | 85.16M |
NewAmsterdam Pharma Company | 33.59M |
ARVN News
- 2 days ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Arvinas, Inc. (ARVN) And Encourages Shareholders to Connect - Accesswire
- 4 days ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Arvinas, Inc. (ARVN) And Encourages Investors to Connect - Accesswire
- 5 days ago - Bronstein, Gewirtz & Grossman, LLC Encourages Arvinas, Inc. (ARVN) Stockholders to Inquire about Securities Investigation - Accesswire
- 6 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Arvinas, Inc. (ARVN) and Encourages Investors to Learn More About the Investigation - Accesswire
- 6 days ago - Arvinas to Present at Piper Sandler 36th Annual Healthcare Conference - GlobeNewsWire
- 7 days ago - Arvinas, Inc. (ARVN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Accesswire
- 7 days ago - Arvinas Announces Upcoming Vepdegestrant Poster Presentations at the 2024 San Antonio Breast Cancer Symposium - GlobeNewsWire
- 8 days ago - Arvinas, Inc. (ARVN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - Accesswire